Eli Lilly Has More Than an Ozempic Competitor -- Much More

Submitted by admin on February 21, 2024 - 11:14am

Source:

Motley Fool

News Tags:

Headline:

snippet:

Eli Lilly is enjoying impressive revenue growth fueled by high demand for its diabetes treatments.
However, the company also develops medications for cancer, plaque psoriasis, and obesity.
Lilly is also potentially at the brink of entering the Alzheimer's market, which is forecast to be valued over $13 billion by 2030.

Search form